Royalty Pharma plc (RPRX) Executive Team
Royalty Pharma executive team at a glance
Royalty Pharma lists 10 executives, led by Pablo Legorreta, Founder, Chairman of the Board & CEO (age 62). Terrance P. Coyne is the company's Executive VP & CFO.
In fiscal year 2025 the highest-paid executive was Pablo Legorreta, Founder, Chairman of the Board & CEO, with total pay of $44.02 million. The 5 executives with reported pay received $51.38 million in all.
The average age of the executives with a known age is 55; the youngest is 49 and the oldest 62.
Titles, ages and pay from company filings; pay for fiscal year 2025.
Royalty Pharma plc
Executive Team
Mr. Pablo Legorreta
Founder, Chairman of the Board & CEO
Mr. Terrance P. Coyne
Executive VP & CFO
Mr. Christopher Hite
Chairman of Partnering & Investments
Dr. Marshall Jonathan Urist M.D., Ph.D.
Head of Research & Investments
Mr. Greg Butz
Executive Vice President of Partnering & Investments
Mr. Eric Cornelius Schneider
Senior VP & Chief Technology Officer
Dr. James Folmar Reddoch Ph.D.
Executive VP of Investments & Chief Scientific Officer
Mr. George Grofik C.F.A., CPA
Senior VP and Head of Investor Relations & Communications
Mr. Arthur Richard McGivern J.D.
Executive VP of Investment & Chief Legal Officer
Ms. Molly Sawaya
Executive VP & Head of Human Capital
Royalty Pharma executive pay, fiscal year 2025
| Executive | Title | Age | Total pay |
|---|---|---|---|
| Pablo Legorreta | Founder, Chairman of the Board & CEO | 62 | $44.02 million |
| James Folmar Reddoch Ph.D. | Executive VP of Investments & Chief Scientific Officer | 55 | $3.40 million |
| Terrance P. Coyne | Executive VP & CFO | – | $1.32 million |
| Christopher Hite | Chairman of Partnering & Investments | 58 | $1.32 million |
| Marshall Jonathan Urist M.D., Ph.D. | Head of Research & Investments | 49 | $1.32 million |
Total pay as reported for the fiscal year; it can include salary, bonus and stock awards.
Questions and answers
Who is the CEO of Royalty Pharma?
Pablo Legorreta (Founder, Chairman of the Board & CEO), age 62; total pay in fiscal year 2025 was $44.02 million.
Who is Royalty Pharma's chief financial officer?
Terrance P. Coyne (Executive VP & CFO).
Who is the highest-paid executive at Royalty Pharma?
Pablo Legorreta, Founder, Chairman of the Board & CEO, with total pay of $44.02 million in fiscal year 2025.
Who are Royalty Pharma's top executives?
Pablo Legorreta (Founder, Chairman of the Board & CEO), Terrance P. Coyne (Executive VP & CFO), Christopher Hite (Chairman of Partnering & Investments), Marshall Jonathan Urist M.D., Ph.D. (Head of Research & Investments) and Greg Butz (Executive Vice President of Partnering & Investments), and 5 more.
